File Download
  Links for fulltext
     (May Require Subscription)
Supplementary

Article: The impact of dexmedetomidine added to ropivicaine for transversus abdominis plane block on stress response in laparoscopic surgery: a randomized controlled trial

TitleThe impact of dexmedetomidine added to ropivicaine for transversus abdominis plane block on stress response in laparoscopic surgery: a randomized controlled trial
Authors
KeywordsDexmedetomidine
Nerve block
Abdominal muscles
Stress response
Laparoscopy
Issue Date2019
PublisherBioMed Central Ltd. The Journal's web site is located at http://www.biomedcentral.com/bmcanesthesiol/
Citation
BMC Anesthesiology, 2019, v. 19 n. 1, p. article no. 181 How to Cite?
AbstractBackground: Intravenous dexmedetomidine is known to attenuate stress response in patients undergoing laparoscopic surgery. We investigated whether the addition of the highly selective alpha-2 adrenergic agonist dexmedetomidine into ropivacaine for ultrasound-guided transversus abdominis plane block could inhibit stress response during laparoscopic surgery, and determined the optimal dose of dexmedetomidine in it. Methods: One hundred and twenty-five patients undergoing laparoscopic gynecological surgery were included in this prospective and randomized double-blind study. Patients received general anesthesia with or without a total of 60 ml of 0.2% ropivacaine in combination with low (0.25 μg/kg), medium (0.50 μg/kg) or high dose (1.0 μg/kg) of dexmedetomidine for the four-quadrant transversus abdominis plane block (n = 25). The primary outcomes were stress marker levels during the operation. Results: One hundred and twenty patients completed the study protocol. Dexmedetomidine added to ropivacaine for transversus abdominis plane block significantly reduced serum levels of cortisol, norepinephrine, epinephrine, interleukin-6, blood glucose, mean arterial pressure and heart rate in a dose-dependent manner (P < 0.05), accompanied with decreased anesthetic and opioid consumption during the operation (P < 0.05), but the high dose of dexmedetomidine induced higher incidences of bradycardia than low or medium dose of dexmedetomidine (P < 0.05). Conclusion: The addition of dexmedetomidine at the dose of 0.5 μg/kg into ropivacaine for ultrasound-guided transversus abdominis plane block is the optimal dose to inhibit stress response with limited impact on blood pressure and heart rate in patients undergoing laparoscopy gynecological surgery. Trial registration: This study was registered at www.chictr.org.cn on November 6th, 2016 (ChiCTR-IOR-16009753).
Persistent Identifierhttp://hdl.handle.net/10722/293738
ISSN
2021 Impact Factor: 2.376
2020 SCImago Journal Rankings: 0.703
PubMed Central ID
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorQin, Z-
dc.contributor.authorXiang, C-
dc.contributor.authorLi, H-
dc.contributor.authorLiu, T-
dc.contributor.authorZhan, L-
dc.contributor.authorXia, Z-
dc.contributor.authorZhang, M-
dc.contributor.authorLai, J-
dc.date.accessioned2020-11-23T08:21:07Z-
dc.date.available2020-11-23T08:21:07Z-
dc.date.issued2019-
dc.identifier.citationBMC Anesthesiology, 2019, v. 19 n. 1, p. article no. 181-
dc.identifier.issn1471-2253-
dc.identifier.urihttp://hdl.handle.net/10722/293738-
dc.description.abstractBackground: Intravenous dexmedetomidine is known to attenuate stress response in patients undergoing laparoscopic surgery. We investigated whether the addition of the highly selective alpha-2 adrenergic agonist dexmedetomidine into ropivacaine for ultrasound-guided transversus abdominis plane block could inhibit stress response during laparoscopic surgery, and determined the optimal dose of dexmedetomidine in it. Methods: One hundred and twenty-five patients undergoing laparoscopic gynecological surgery were included in this prospective and randomized double-blind study. Patients received general anesthesia with or without a total of 60 ml of 0.2% ropivacaine in combination with low (0.25 μg/kg), medium (0.50 μg/kg) or high dose (1.0 μg/kg) of dexmedetomidine for the four-quadrant transversus abdominis plane block (n = 25). The primary outcomes were stress marker levels during the operation. Results: One hundred and twenty patients completed the study protocol. Dexmedetomidine added to ropivacaine for transversus abdominis plane block significantly reduced serum levels of cortisol, norepinephrine, epinephrine, interleukin-6, blood glucose, mean arterial pressure and heart rate in a dose-dependent manner (P < 0.05), accompanied with decreased anesthetic and opioid consumption during the operation (P < 0.05), but the high dose of dexmedetomidine induced higher incidences of bradycardia than low or medium dose of dexmedetomidine (P < 0.05). Conclusion: The addition of dexmedetomidine at the dose of 0.5 μg/kg into ropivacaine for ultrasound-guided transversus abdominis plane block is the optimal dose to inhibit stress response with limited impact on blood pressure and heart rate in patients undergoing laparoscopy gynecological surgery. Trial registration: This study was registered at www.chictr.org.cn on November 6th, 2016 (ChiCTR-IOR-16009753).-
dc.languageeng-
dc.publisherBioMed Central Ltd. The Journal's web site is located at http://www.biomedcentral.com/bmcanesthesiol/-
dc.relation.ispartofBMC Anesthesiology-
dc.rightsBMC Anesthesiology. Copyright © BioMed Central Ltd.-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.subjectDexmedetomidine-
dc.subjectNerve block-
dc.subjectAbdominal muscles-
dc.subjectStress response-
dc.subjectLaparoscopy-
dc.titleThe impact of dexmedetomidine added to ropivicaine for transversus abdominis plane block on stress response in laparoscopic surgery: a randomized controlled trial-
dc.typeArticle-
dc.identifier.emailXia, Z: zyxia@hkucc.hku.hk-
dc.identifier.authorityXia, Z=rp00532-
dc.description.naturepublished_or_final_version-
dc.identifier.doi10.1186/s12871-019-0859-7-
dc.identifier.pmid31604428-
dc.identifier.pmcidPMC6790018-
dc.identifier.scopuseid_2-s2.0-85073161702-
dc.identifier.hkuros319115-
dc.identifier.volume19-
dc.identifier.issue1-
dc.identifier.spagearticle no. 181-
dc.identifier.epagearticle no. 181-
dc.identifier.isiWOS:000489759500001-
dc.publisher.placeUnited Kingdom-
dc.identifier.issnl1471-2253-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats